ArticleJournal of clinical medicine research2011

Rheumatoid arthritis: refractory to infliximab, a tumor necrosis factor inhibitor.

Hana Maizuliana Bt Solehan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.